Korro Bio (KRRO) Assets (2018 - 2026)
Korro Bio (KRRO) reported Assets of $163.45 million for Q2 2026, down 9.4% from $180.43 million a year earlier and down 11.0% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Korro Bio posted Assets of $113.51 million, down 49.8% from FY2024.
- Assets has a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
- By year, Assets came in at $226.24 million in FY2024 (+2.1%), $221.66 million in FY2023 (+200.6%), $73.74 million in FY2022 (-60.2%) and $185.36 million in FY2021 (-30.0%).
- Five-year quarterly Assets spans a low of $46.35 million in Q3 2023 and a high of $249.59 million in Q2 2024.
- Year over year, Assets has now declined in each of the last five quarters, with growth averaging 37.5% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2024 (growth of 425.5%); the low point was Q3 2023 (a decline of 65.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $183.62 million (Q1 2026), $113.51 million (Q4 2025) and $161.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Korro Bio | 281.05 Mn | -128.11 Mn | - | 148.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 148.12 Mn |
| Jun 30, 2026 | 163.45 Mn |
| Mar 31, 2026 | 183.62 Mn |
| Dec 31, 2025 | 113.51 Mn |
| Sep 30, 2025 | 161.55 Mn |
| Jun 30, 2025 | 180.43 Mn |
| Mar 31, 2025 | 202.21 Mn |
| Dec 31, 2024 | 226.24 Mn |
| Sep 30, 2024 | 243.54 Mn |
| Jun 30, 2024 | 249.59 Mn |
| Mar 31, 2024 | 197.99 Mn |
| Dec 31, 2023 | 221.66 Mn |
| Sep 30, 2023 | 46.35 Mn |
| Jun 30, 2023 | 79.38 Mn |
| Mar 31, 2023 | 101.50 Mn |
| Dec 31, 2022 | 73.74 Mn |
| Sep 30, 2022 | 136.01 Mn |
| Jun 30, 2022 | 149.66 Mn |
| Mar 31, 2022 | 164.94 Mn |
| Dec 31, 2021 | 185.36 Mn |
API Access
Korro Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();